https://dxm-atlas.org/en/interactions/moclobemide/
CompareKey points for this combination
Moclobemide inhibits MAO-A. A small human study also found reduced DXM O-demethylation with unchanged DXO N-demethylation [43]. That study measured metabolism. Another source reports a fatal DXM–moclobemide overdose [27]. One such case cannot establish the frequency of complications during recreational use.
General concepts in this text
Metabolite
A substance formed when another substance is chemically transformed in the body.
Some transformation products retain pharmacological activity.
Sources: Metabolite
- IUPHAR Pharmacology Education Project: Clinical pharmacokinetics · Live page accessed 2026-10-12; revision label unavailable
MAO-A
A form of the MAO enzyme involved in breaking down some chemical messengers, including serotonin.
These messengers are monoamines. MAO-A and MAO-B are two different forms of monoamine oxidase.
Sources: MAO-A
- MedlinePlus Genetics: MAOA gene — Normal Function · Page last updated 2017-05-01; accessed 2026-10-13
- Edmondson, Binda, Mattevi: Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B · Arch Biochem Biophys. 2007;464(2):269–276; DOI 10.1016/j.abb.2007.05.006; PMID 17573034
Drug metabolism
Chemical transformation of a medicine in the body.
The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.
Sources: Drug metabolism
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
Demethylation
A chemical change that removes one or more methyl groups from a compound.
A methyl group contains one carbon atom and three hydrogen atoms.
Sources: Demethylation
- NLM MedGen: Demethylation (C0598864) · Live official entry read 2026-10-13; definition attributed to MeSH; separate revision date unavailable
- NCI Dictionary of Cancer Terms: methyl group · Complete live entry read 2026-10-13; no visible update date
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: medium
Confidence in direct human evidence involving DXM: medium
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
Can the amount reaching the body change?
ⓘ
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
How can the effects add up?
ⓘ
MAO — monoamine oxidase
An enzyme involved in breaking down serotonin.
Breakdown and reuptake are different processes.
Sources: MAO — monoamine oxidase
- OpenStax: Neurotransmitters Made from Amino Acids · Introduction to Behavioral Neuroscience, published 2024-11-13
Serotonin toxicity
A condition caused by excessive serotonin activity in the nervous system.
Also called serotonin syndrome. Features can include tremor and involuntary muscle jerks, raised body temperature, a fast heartbeat, agitation or confusion.
Sources: Serotonin toxicity
- Ables and Nagubilli: Prevention, Diagnosis, and Management of Serotonin Syndrome · American Family Physician 81(9), 1139–1142 (2010)
- Chiew and Isbister: Management of serotonin syndrome (toxicity) · British Journal of Clinical Pharmacology 91(3), 654–661 (2025); first published 26 June 2024; DOI 10.1111/bcp.16152
Sources
Check the review’s wording
- [27] A fatal intoxication case due to the serotonin syndrome induced by dextromethorphan and moclobemide overdose · Open publication
- [43] Inhibition of dextromethorphan metabolism by moclobemide · Open publication